Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Hu

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
A Phase 2 Exploratory Trial Evaluating Computed Tomography-Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal CancerJoseph K Kim, Moses Tam, Sungheon Gene Kim, et al.
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
Journal of Geriatric Oncology|April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancerJulie A Kish, Qiang Zhang, Corey J Langer, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
A Phase 2 Exploratory Trial Evaluating Computed Tomography-Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal CancerJoseph K Kim, Moses Tam, Sungheon Gene Kim, et al.
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
Journal of Geriatric Oncology|April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancerJulie A Kish, Qiang Zhang, Corey J Langer, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 6